Cheng Kong Shih
Director Ejecutivo en Xuanzhu Biopharmaceutical Co., Ltd. .
Perfil
Cheng Kong Shih is currently the Vice Chairman, Chief Scientist & General Manager at Xuanzhu Biopharmaceutical Co., Ltd.
He started this position in 2021.
Prior to his current role, he obtained a doctorate degree from The Rockefeller University.
Cargos activos de Cheng Kong Shih
| Empresas | Cargo | Inicio |
|---|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
 Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Director Ejecutivo | 01/12/2018 |
Formación de Cheng Kong Shih.
| The Rockefeller University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Xuanzhu Biopharmaceutical Co., Ltd.
Xuanzhu Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xuanzhu Biopharmaceutical Co., Ltd. engages in the research and development of chemical and biological drugs. Its products include small molecular chemical drugs, monoclonal antibodies, bispecific antibodies, and antibody conjugated drugs. The company was founded in 2002 and is headquartered in Shijiazhuang, China. | Commercial Services |
- Bolsa de valores
- Insiders
- Cheng Kong Shih
